Literature DB >> 4292227

Lipid composition of mitochondria from bovine heart, liver, and kidney.

S Fleischer, G Rouser, B Fleischer, A Casu, G Kritchevsky.   

Abstract

Highly purified preparations of mitochondria from bovine heart, liver, and kidney were isolated and characterized by electron microscopy, oxidative phosphorylation ability, cytochrome c reductase activity, and cytochrome content. Components of lipid extracts of the preparations were determined by thin-layer chromatography, diethylaminoethyl-cellulose column chromatography, and spectrophotometric procedures. The major phospholipids were identified by their chromatographic behavior, IR spectrometry, and paper chromatography of their hydrolysis products. The lipid content of the mitochondria paralleled that of the components of the electron transfer chain, heart mitochondria being richest and liver mitochondria poorest in lipid. Heart mitochondria contain equal concentrations of coenzyme Q and cholesterol (1%); the highest cholesterol content (4.7%) was found in mitochondria from kidney. The phospholipids of mitochondria from the three organs were qualitatively and quantitatively very similar. The major polar lipid components (cardiolipin, choline glycerophosphatides, and ethanolamine glycerophosphatides) were present in a molar ratio of 1:4:4. It is suggested that mitochondria from different sources contain characteristic lipids, mainly phospholipids, of which cardiolipin is particularly diagnostic of the source of the mitochondria.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4292227

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  58 in total

1.  The second coenzyme Q1 binding site of bovine heart NADH: coenzyme Q oxidoreductase.

Authors:  Yumiko Nakashima; Kyoko Shinzawa-Itoh; Kenji Watanabe; Kazuki Naoki; Nobuko Hano; Shinya Yoshikawa
Journal:  J Bioenerg Biomembr       Date:  2002-04       Impact factor: 2.945

2.  Butylated hydroxytoluene and inorganic phosphate plus Ca2+ increase mitochondrial permeability via mutually exclusive mechanisms.

Authors:  P M Sokolove; L M Haley
Journal:  J Bioenerg Biomembr       Date:  1996-04       Impact factor: 2.945

3.  Binding to and photo-oxidation of cardiolipin by the phthalocyanine photosensitizer Pc 4.

Authors:  Myriam E Rodriguez; Junhwan Kim; Grace B Delos Santos; Kashif Azizuddin; Jeffrey Berlin; Vernon E Anderson; Malcolm E Kenney; Nancy L Oleinick
Journal:  J Biomed Opt       Date:  2010 Sep-Oct       Impact factor: 3.170

4.  Control by cytochrome c oxidase of the cellular oxidative phosphorylation system depends on the mitochondrial energy state.

Authors:  Claudia Piccoli; Rosella Scrima; Domenico Boffoli; Nazzareno Capitanio
Journal:  Biochem J       Date:  2006-06-15       Impact factor: 3.857

5.  Accumulation of a glycerolphospholipid in classical niemann-pick disease.

Authors:  G Rouser; G Kritchevsky; A G Knudson; G Simon
Journal:  Lipids       Date:  1968-05       Impact factor: 1.880

6.  Studies on plasma membranes : XVIII. lipid class composition of plasma membranes isolated from rat and mouse liver and hepatomas.

Authors:  R P van Hoeven; P Emmelot
Journal:  J Membr Biol       Date:  1972-12       Impact factor: 1.843

7.  Lipid composition of purified vesicular stomatitis viruses.

Authors:  J J McSharry; R R Wagner
Journal:  J Virol       Date:  1971-01       Impact factor: 5.103

8.  Growth hormone and liver mitochondria: effects on phospholipid composition and fatty acyl distribution.

Authors:  S Clejan; V T Maddaiah
Journal:  Lipids       Date:  1986-11       Impact factor: 1.880

9.  Modeling mitochondrial bioenergetics with integrated volume dynamics.

Authors:  Jason N Bazil; Gregery T Buzzard; Ann E Rundell
Journal:  PLoS Comput Biol       Date:  2010-01-01       Impact factor: 4.475

10.  Evidence for mitochondrial respiratory deficiency in rat rhabdomyosarcoma cells.

Authors:  Vanessa E Jahnke; Odile Sabido; Aurélia Defour; Josiane Castells; Etienne Lefai; Damien Roussel; Damien Freyssenet
Journal:  PLoS One       Date:  2010-01-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.